Product Code: ETC6182438 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
This market encompasses genetic testing for inherited cancer risk, primarily focusing on breast, ovarian, colorectal, and prostate cancers. Rising consumer awareness, coupled with the availability of direct-to-consumer testing options and integration of genomics in healthcare, are bolstering demand. Government support for personalized medicine and cancer prevention programs further accelerates market growth.
Hereditary cancer testing is on the rise in Australia, driven by growing public awareness, falling costs of genetic sequencing, and support from national screening programs. The trend is shifting from single-gene to multi-gene panel testing, which provides comprehensive risk profiles and enables more informed decision-making for patients and clinicians. Direct-to-consumer genetic testing services are also making an impact, though clinical validation and counseling remain essential components. Integration with electronic health records and personalized care plans is another emerging trend.
The Australia Hereditary Cancer Testing Market faces challenges surrounding the accessibility and affordability of genetic testing. The demand for genetic tests is increasing, but there is still a gap in insurance coverage for these services, limiting their widespread use. Additionally, some patients and healthcare providers are hesitant about the implications of genetic testing, which can hinder adoption rates.
The hereditary cancer testing market in Australia offers immense potential as genetic screening becomes a cornerstone of preventive healthcare. Investment in next-generation sequencing platforms, direct-to-consumer testing models, and bioinformatics solutions can generate high returns. Public-private partnerships to increase testing accessibility and education can also accelerate market growth.
Australias hereditary cancer testing market is driven by government policies that prioritize the identification and treatment of individuals at risk of genetic cancers. The government supports genetic testing programs through the Medicare Benefits Schedule (MBS), which provides funding for genetic testing services. There is also a focus on raising awareness among the general population and healthcare providers about the importance of early detection of hereditary cancers. Research funding and public health programs are further supporting the development of advanced testing technologies in the market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Hereditary Cancer Testing Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Hereditary Cancer Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Hereditary Cancer Testing Market - Industry Life Cycle |
3.4 Australia Hereditary Cancer Testing Market - Porter's Five Forces |
3.5 Australia Hereditary Cancer Testing Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 Australia Hereditary Cancer Testing Market Revenues & Volume Share, By Diagnosis Type, 2021 & 2031F |
3.7 Australia Hereditary Cancer Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Australia Hereditary Cancer Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Australia Hereditary Cancer Testing Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Hereditary Cancer Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Hereditary Cancer Testing Market Trends |
6 Australia Hereditary Cancer Testing Market, By Types |
6.1 Australia Hereditary Cancer Testing Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Hereditary Cancer Testing Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 Australia Hereditary Cancer Testing Market Revenues & Volume, By Multi Panel Set, 2021- 2031F |
6.1.4 Australia Hereditary Cancer Testing Market Revenues & Volume, By Single Site Genetic Test, 2021- 2031F |
6.2 Australia Hereditary Cancer Testing Market, By Diagnosis Type |
6.2.1 Overview and Analysis |
6.2.2 Australia Hereditary Cancer Testing Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.2.3 Australia Hereditary Cancer Testing Market Revenues & Volume, By Imaging, 2021- 2031F |
6.2.4 Australia Hereditary Cancer Testing Market Revenues & Volume, By Lab Tests, 2021- 2031F |
6.3 Australia Hereditary Cancer Testing Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Australia Hereditary Cancer Testing Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.3.3 Australia Hereditary Cancer Testing Market Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021- 2031F |
6.3.4 Australia Hereditary Cancer Testing Market Revenues & Volume, By Microarray, 2021- 2031F |
6.4 Australia Hereditary Cancer Testing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Australia Hereditary Cancer Testing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Australia Hereditary Cancer Testing Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Australia Hereditary Cancer Testing Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.4.5 Australia Hereditary Cancer Testing Market Revenues & Volume, By Radiology Centers, 2021- 2031F |
6.4.6 Australia Hereditary Cancer Testing Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.4.7 Australia Hereditary Cancer Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Australia Hereditary Cancer Testing Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Australia Hereditary Cancer Testing Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.5.3 Australia Hereditary Cancer Testing Market Revenues & Volume, By Retail Sales, 2021- 2031F |
7 Australia Hereditary Cancer Testing Market Import-Export Trade Statistics |
7.1 Australia Hereditary Cancer Testing Market Export to Major Countries |
7.2 Australia Hereditary Cancer Testing Market Imports from Major Countries |
8 Australia Hereditary Cancer Testing Market Key Performance Indicators |
9 Australia Hereditary Cancer Testing Market - Opportunity Assessment |
9.1 Australia Hereditary Cancer Testing Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 Australia Hereditary Cancer Testing Market Opportunity Assessment, By Diagnosis Type, 2021 & 2031F |
9.3 Australia Hereditary Cancer Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Australia Hereditary Cancer Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Australia Hereditary Cancer Testing Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Hereditary Cancer Testing Market - Competitive Landscape |
10.1 Australia Hereditary Cancer Testing Market Revenue Share, By Companies, 2024 |
10.2 Australia Hereditary Cancer Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |